4//SEC Filing
SCHIMMEL PAUL 4
Accession 0000950170-24-064218
CIK 0001339970other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 7:16 PM ET
Size
5.4 KB
Accession
0000950170-24-064218
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
SCHIMMEL PAUL
Director
Transactions
- Award
Stock Option (right to buy)
2024-05-22+24,000→ 24,000 totalExercise: $1.86Exp: 2034-05-22→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001236447
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 7:16 PM ET
- Size
- 5.4 KB